Abstract
BackgroundThe RA Disease-Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study–1 (RADIUS 1) was a real-world, prospective, 5-year, observational study of 4968 patients (aged ≥18 y) with RA (per 1987 American...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have